FDA granted NeoPharm, Inc. (Lake Fo...
FDA granted NeoPharm, Inc. (Lake Forest, IL) orphan remedy status for its anti-mesothelin monoclonal antibody toxin, SS1-PE38 designed to treat ovarian cancer and mesothelioma, a form of lung cancer. Orfadin (Swedish Orphan International AB, Stockholm, Sweden, nitisinone) was granted orphan unsalable article status by the FDA. The physic is designed to treat hereditary tyrosinemia representation I HT-1), a pediatric disease that
|